Company / Profit Margin
Revolution Medicines, Inc. Profit Margin History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-3768.3%
FY2023
5-year range
-3768.3% / -95.3%
FY2019-FY2023
Trend
-1397.5%
vs FY2022
Sector context
#138 of 145
Health Care
What the data says
Profit Margin changed -1398% YoY in FY2023, a notable deviation from the 4-year average annual change of -406%.
Based on SEC 10-K filings.
-3768.3% in FY2023 with a 3-year CAGR of -3561.0%.
Declined from -95.3% to -3768.3% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -3561.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 145This company -3768.3% Sector average -792.7%
▼
-375.4% below sector average
Key checks
Key Insights
- In FY2023, profit margin decreased 1397.5% year-over-year.
- Currently 2975.6pp below the Health Care sector average.
- Peak profit margin was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -3768.3% | -1397.5% |
| FY2022 | -251.6% | -164.2% |
| FY2021 | -95.3% | +54.0% |
| FY2020 | -207.2% | -117.6% |
| FY2019 | -95.3% | - |
| FY2018 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026